Original Article
Homocysteine as a Predictive Factor for Hip Fracture in Older Persons
N Engl J Med 2004; 350:2042-2049May 13, 2004
- Abstract
Background
The increased prevalence of osteoporosis among people with homocystinuria suggests that a high serum homocysteine concentration may weaken bone by interfering with collagen cross-linking, thereby increasing the risk of osteoporotic fracture. We examined the association between the total homocysteine concentration and the risk of hip fracture in men and women enrolled in the Framingham Study.
Methods
We studied 825 men and 1174 women, ranging in age from 59 to 91 years, from whom blood samples had been obtained between 1979 and 1982 to measure plasma total homocysteine. The participants in our study were followed from the time that the sample was obtained through June 1998 for incident hip fracture. Sex-specific, age-adjusted incidence rates of hip fracture were calculated for quartiles of total homocysteine concentrations. Cox proportional-hazards regression was used to calculate hazard ratios for quartiles of homocysteine values.
Results
The mean (±SD) plasma total homocysteine concentration was 13.4±9.1 μmol per liter in men and 12.1±5.3 μmol per liter in women. The median duration of follow-up was 12.3 years for men and 15.0 years for women. There were 41 hip fractures among men and 146 among women. The age-adjusted incidence rates per 1000 person-years for hip fracture, from the lowest to the highest quartile for total homocysteine, were 1.96 (95 percent confidence interval, 0.52 to 3.41), 3.24 (0.97 to 5.52), 4.43 (1.80 to 7.07), and 8.14 (4.20 to 12.08) for men and 9.42 (5.72 to 13.12), 7.01 (4.29 to 9.72), 9.58 (6.42 to 12.74), and 16.57 (11.84 to 21.30) for women. Men and women in the highest quartile had a greater risk of hip fracture than those in the lowest quartile — the risk was almost four times as high for men and 1.9 times as high for women.
Conclusions
These findings suggest that the homocysteine concentration, which is easily modifiable by means of dietary intervention, is an important risk factor for hip fracture in older persons.
Media in This Article
Figure 1
Multivariable-Adjusted Hazard Ratios for the Risk of Hip Fracture, According to the Quartile of Total Homocysteine Concentration.Table 1
Baseline Characteristics of the Study Participants.Article Activity
- Article
Homocysteine is an amino acid intermediate formed during the metabolism of methionine. Homocystinuria, a rare autosomal recessive biochemical abnormality, causes elevated plasma concentrations of homocysteine and severe occlusive vascular disease.1 This observation has led to studies that implicate plasma homocysteine as a risk factor for cardiovascular disease.2,3 In patients with homocystinuria, there is an increased prevalence of skeletal deformities, including osteoporosis,1,4,5 which is a primary risk factor for hip fracture. Thus, elevated plasma homocysteine concentrations may be associated with osteoporosis and may increase the risk of hip fracture, which can lead to substantial disability,6 high medical costs,7 and death.8 We examined the association between plasma total homocysteine concentrations and the risk of hip fracture in a group of older men and women enrolled in the Framingham Study.
Methods
Participants
The Framingham Study was begun in 1948 with the primary goal of evaluating risk factors for heart disease. A total of 5209 men and women who ranged in age from 28 to 62 years were recruited from a sample of two thirds of the residences in Framingham, Massachusetts, and have been examined biennially for more than 50 years.9 The participants in the present study included 2043 older subjects from whom blood samples were obtained at the 16th biennial examination (between 1979 and 1982). Forty-four subjects with prior hip fractures were excluded, leaving 1999 participants (mean age, 70 years; range, 59 to 91) who were followed for an incident hip fracture from the date when the blood sample was obtained.
Homocysteine Measurement
Blood samples were collected while the subjects were in a nonfasting state and were frozen immediately and stored at or below –20°C. In 1997, the samples were thawed and the plasma total homocysteine concentrations were measured with the use of high-performance liquid chromatography with fluorometric detection.10 The stability of measurements of total homocysteine from plasma or serum stored at temperatures at or below –20°C has been validated previously.11 The coefficient of variation for this assay was 9 percent.12
Assessment of Hip Fracture
As reported previously,13 all records of hospitalizations and deaths for the study participants were systematically reviewed for occurrences of hip fracture. Beginning in 1983 (18th biennial examination in the Framingham Study), hip fractures were reported by interview at each biennial examination or by telephone interview for participants unable to attend an examination. Reported hip fractures were confirmed by a review of medical records and radiographic and operative reports. Hip fracture was defined as a first-time fracture of the proximal femur that occurred in the absence of overwhelming trauma (e.g., a motor vehicle accident).
Covariables
Potential confounders obtained from data from the 16th biennial examination (except where noted) included sex, age, height, weight, smoking status, caffeine consumption, alcohol consumption, educational level (≥12 years or <12 years), and current use or nonuse of estrogen among women. Height without shoes was measured to the nearest quarter inch (0.6 cm). Weight in pounds (without shoes) was measured with the use of a standard balance-beam scale at each examination. Smoking was measured at the 15th examination (between 1977 and 1979) as the average number of cigarettes smoked per day in the previous two years. Caffeine consumption in the form of tea and coffee was quantified as previously described.14 At the 15th examination alcohol consumption (beer, wine, or spirits) was calculated as the number of ounces consumed per week, as previously reported.15 Participants were classified at baseline (16th biennial examination) as either having a prior diagnosis of cardiovascular disease or not, according to previously published diagnostic criteria.16 A score for physical function was calculated as a weighted sum of the participants' self-reported responses to nine questions selected from those developed by Nagi to measure physical function,17 which were asked at the 14th biennial examination (between 1975 and 1978),18 and a score for cognitive status was obtained with the use of the Folstein Mini–Mental State Examination,19 which was administered at the 17th examination (between 1981 and 1984), as previously described.20
Statistical Analysis
Owing to a skewed distribution, total homocysteine concentrations were analyzed as quartiles and as continuous, natural-log–transformed values. Incidence rates of hip fracture (the number of incident cases divided by the number of person-years at risk for fracture) were calculated for quartiles and were standardized for age in five-year age groups on the basis of sex-specific age distributions of all the study participants. For each participant, the accumulation of person-years at risk started from the collection of the blood sample and continued until the first occurrence of hip fracture, death, last contact with the participant, or the end of follow-up (June 30, 1998, for all study participants). Cox proportional-hazards regression was used to calculate the hazard ratios and the 95 percent confidence intervals that were used to estimate the relative increase in the risk of hip fracture for each of the three higher quartiles as compared with the lowest quartile (referent); it was also used to test for a linear trend in the hazard ratios across all the quartiles. To estimate the absolute association between homocysteine concentrations and hip fracture, differences in risk between the highest and lowest quartiles were calculated with 95 percent confidence intervals.
The risk of hip fracture within each quartile was calculated with the use of the Cox regression model as 1 minus the probability of survival without a hip fracture to the median follow-up time. Cox regression was also used to estimate the hazard ratio for hip fracture for each increase of 1 SD in continuous, log-transformed total homocysteine values. All analyses were conducted separately for men and women. Regression analyses used to calculate the hazard ratios were adjusted for potential confounders by including data on age, height, weight, smoking status, caffeine consumption, alcohol consumption, educational level, and current use or nonuse of estrogen among women. To estimate the risk of fracture within quartiles in the Cox regression models, potential confounders were assigned mean levels for continuous covariates and the most prevalent category for dichotomous variables.
People with higher homocysteine concentrations may have an increased risk of cardiovascular disease and cognitive dysfunction,21 conditions that limit activity and result in greater frailty and an increased risk of hip fracture. To address cardiovascular disease as a potential confounder, we performed additional analyses adjusted for the presence or absence of cardiovascular disease and for measures of physical function and cognitive status. Because the scores for cognitive status were not collected until the 17th examination, analyses involving this covariate started at that examination. To investigate the possible effect of changes in weight, we adjusted a model for time-varying weight. To determine whether a subgroup of participants with extremely high homocysteine concentrations who were in the highest quartile might be driving the association between homocysteine and hip fracture, we repeated our original analysis but excluded subjects considered to have extreme homocysteine values within the highest quartile. For all statistical analyses, we used SAS/STAT software, version 8.1 (SAS Institute).
Results
Table 1Table 1
Baseline Characteristics of the Study Participants. lists the baseline characteristics of the participants according to sex. The mean (±SD) age among the 825 men was 69.5 years, and among the 1174 women it was 70.3 years. The men were taller than the women, weighed more, smoked more cigarettes, consumed more alcohol, and had higher mean total homocysteine concentrations. Among the men the median follow-up period was 12.3 years, and among the women it was 15.0 years. During follow-up, 41 of the men and 146 of the women sustained hip fractures.The characteristics of the study participants across the quartiles of total homocysteine concentrations are shown in Table 2Table 2
Homocysteine Concentrations and Ages of Participants.. Among men, the mean total homocysteine concentration in the lowest quartile (quartile 1) was 8.5±0.9 μmol per liter, and among women it was 7.6±1.0. In the highest quartile (quartile 4), among men the total homocysteine concentrations ranged from 15.01 to 219.80 μmol per liter, with a mean of 20.8±15.7. Among women in quartile 4, concentrations ranged from 13.47 to 59.27 μmol per liter, with a mean of 18.6±6.4. Mean age increased from the lowest to the highest quartile among men (quartile 1, 67.9 years; and quartile 4, 71.8) and among women (quartile 1, 68.3 years; and quartile 4, 73.3). The age ranges for men and women were similar in all quartiles.Table 3Table 3
Age-Adjusted Incidence Rates of Hip Fracture According to Quartile of Homocysteine Level. lists the age-adjusted incidence rates of hip fracture according to the quartile of total homocysteine concentration. Among men, the number of hip fractures increased monotonically from 5 in quartile 1 to 17 in quartile 4. Among women, however, the number of hip fractures was similar from quartile 1 to quartile 3 (range, 26 to 36) and then increased to 54 in quartile 4. Age-adjusted incidence rates among men increased across the quartiles, from 1.96 fractures per 1000 person-years in quartile 1 to 8.14 per 1000 person-years in quartile 4. Among women, although the incidence rates were similar from quartile 1 to quartile 3 (range, 7.01 to 9.58 fractures per 1000 person-years), the rate of fracture was higher in quartile 4 (16.57 per 1000 person-years).The results of the multivariable-adjusted Cox proportional-hazards regressions for quartiles of homocysteine concentrations are shown in Figure 1Figure 1
Multivariable-Adjusted Hazard Ratios for the Risk of Hip Fracture, According to the Quartile of Total Homocysteine Concentration.. Whereas men in quartiles 2 and 3 tended to have a higher risk of hip fracture than those in quartile 1 (hazard ratio for quartile 2, 1.67; 95 percent confidence interval, 0.54 to 5.14; hazard ratio for quartile 3, 2.07; 95 percent confidence interval, 0.70 to 6.09), the risk of fracture among men in quartile 4 was almost four times the risk among men in quartile 1 (hazard ratio for quartile 4, 3.84; 95 percent confidence interval, 1.38 to 10.70). The test for a linear trend in hazard ratios across the quartiles was statistically significant (P<0.01), suggesting a linear association between the quartile of homocysteine concentration and the risk of hip fracture. In quartile 4 as compared with quartile 1, there were 8.8 excess fractures per 100 men (95 percent confidence interval, 0.4 to 17.3) for the mean levels of the covariates at 14 years of follow-up.Among the women, there was no apparent increase in the risk of fracture in quartiles 2 and 3 as compared with quartile 1 (hazard ratio for quartile 2, 0.78; 95 percent confidence interval, 0.45 to 1.33; hazard ratio for quartile 3, 1.07; 95 percent confidence interval, 0.64 to 1.78) (Figure 1). Among women in quartile 4, however, the risk of fracture was nearly twice that among women in quartile 1 (hazard ratio for quartile 4, 1.92; 95 percent confidence interval, 1.18 to 3.10). The test for a linear trend in hazard ratios was statistically significant (P<0.01). For women who were not currently receiving estrogen therapy, the difference in the risk of hip fracture between quartiles 4 and 1 for the mean levels of their covariates at 14 years of follow-up was 9.5 excess fractures per 100 participants (95 percent confidence interval, 1.2 to 17.9).
For each increase of 1 SD in the log-transformed total homocysteine concentration, the risk of hip fracture increased by 59 percent in men (1 SD in log-transformed homocysteine concentration, 0.34; hazard ratio, 1.59; 95 percent confidence interval, 1.31 to 1.94) and by 26 percent in women (1 SD, 0.35; hazard ratio, 1.26; 95 percent confidence interval, 1.08 to 1.47). Additional adjustments for cardiovascular disease, physical function, cognitive status, and weight modeled as a time-varying covariate did not change the effect of the homocysteine concentration on the risk of hip fracture for men or women. Among the men in quartile 4, two had homocysteine values (96 and 220 μmol per liter) that were more than double the next highest value. The effect of the homocysteine concentration on the risk of hip fracture was essentially unchanged when our analysis was repeated with these two outliers excluded. There were no extreme homocysteine values among the women.
Discussion
We found that plasma homocysteine concentrations were associated with the risk of hip fracture in both men and women. The study participants in the highest quartile of values for total homocysteine had a significantly higher risk of hip fracture than those in the lowest quartile: by a factor of almost four in men and by a factor of 1.9 in women. The risk of hip fracture was elevated by 59 percent in men and by 26 percent in women for each increase of 1 SD in the log-transformed total homocysteine concentration. The increase in risk across quartiles in men appeared to be monotonic. Despite the statistically significant test for a linear trend in the risk among women, only those in the highest quartile were at increased risk for hip fracture, which suggests a possible threshold effect.
The apparent differences according to sex in the gradient of risk from the lowest to the highest quartile of homocysteine concentrations may be explained by the lower background incidence of hip fracture in men. Because the magnitude of the hazard ratio depends on the risk in the reference group, we provided an absolute measure of the effect of the homocysteine concentration on the risk of hip fracture. The differences in absolute risk between the highest and lowest quartiles for men and women were more similar (8.8 and 9.5 fractures, respectively, per 100 participants at 14 years of follow-up) than the hazard ratios (3.84 and 1.92, respectively). Therefore, the effect of the homocysteine concentration on the risk of hip fracture is most likely very similar in men and women.
To explain the increased prevalence of osteoporosis among patients with homocystinuria, McKusick first proposed that homocysteine interferes with the cross-linking of collagen.22 Later studies supported this hypothesis with evidence of reduced collagen cross-linking in patients with homocystinuria.23,24 Whether these findings in studies of patients with the congenital condition of homocystinuria are directly applicable to normal variations in homocysteine concentrations among adults is unclear.
There is little evidence that homocysteine has a direct effect on bone. One study showed that chicks fed a homocysteine-supplemented diet had altered bone growth, bone matrix, and bone composition as compared with control chicks25 but had similar mechanical strength and indexes of bone formation. This finding suggested that changes in bone geometry may compensate for any weakness caused by possible defects in collagen cross-linking. Future studies are needed to examine the association between homocysteine and the material and structural properties of bone in humans.
Although one previous report failed to find a relation between homocysteine concentrations and bone mineral density,26 studies of genetic association support the concept that homocysteine is involved in the development of osteoporosis. The reduced activity of the enzyme methylenetetrahydrofolate reductase (MTHFR), which is determined by the MTHFR gene, can interfere with the methylation of homocysteine to methionine, possibly resulting in abnormal plasma homocysteine concentrations. A common mutation in the MTHFR gene27 is associated with elevated plasma homocysteine concentrations in patients with reduced plasma folate concentrations.28 The results of studies of bone mass29-32 and fracture30 are not consistent, yet they suggest that there may be a relation between the MTHFR gene and both bone mineral density and the risk of fracture.
If the homocysteine concentration truly is a causal mechanism for the risk of fracture, the public health implications could be substantial. The 1996 mandate of the Food and Drug Administration to fortify enriched grain products with folic acid33 has helped to reduce the prevalence of low folate concentrations (<7 nmol per liter) in persons who are not taking vitamin supplements from 22.0 percent to 1.7 percent and to reduce the prevalence of homocysteine concentrations higher than 13 μmol per liter from 18.7 percent to 9.8 percent.34 It remains to be seen whether this intervention will affect future rates of hip fracture in the United States.
Our study has several potential limitations. First, our findings in white men and women may not be generalizable to other racial and ethnic groups. Second, because blood samples obtained from nonfasting subjects tend to yield higher total homocysteine concentrations than samples from fasting subjects,35 the concentrations in our study may not be comparable to those in other studies in which samples were obtained from fasting subjects. Third, owing to the within-person variability of homocysteine concentrations, the use of a single measurement performed during the 20-year follow-up period may have led to regression dilution, resulting in an underestimate of the relative risk of hip fracture according to the homocysteine concentration.36 Fourth, we were unable to assess potential confounding due to dietary factors, because no dietary information was available at baseline. Because folate and vitamins B12 and B6 are major determinants of homocysteine concentrations in older persons,12,37 the inadequacy of one or more of these vitamins, rather than the homocysteine concentration itself, may be responsible for the observed effect on the risk of hip fracture. Patients with pernicious anemia have decreased bone mineral density at the lumbar spine,38 and in comparison with the general population they have almost double the risk of hip fracture.39 A recent, population-based study showed that older women, but not men, with low bone mineral density had significantly lower vitamin B12 concentrations than older women with higher bone density.40
It is also possible that the effect of homocysteine on the risk of hip fracture is mediated through other nutrients, apart from B vitamins, that we were unable to measure. If there is a direct effect of these dietary factors on the risk of hip fracture, the homocysteine concentration may simply reflect nutritional status. Thus, dietary factors may explain the relation between the plasma homocysteine concentration and the risk of hip fracture observed in our study. Finally, because no data on bone mineral density were available for the study participants at baseline, we were unable to assess whether the effect of homocysteine on hip fracture may be mediated through bone mineral density.
We were not able to establish causality definitively, because plasma homocysteine concentrations may only be a marker for nutritional or metabolic differences that are the real causal factors in hip fracture. Furthermore, we cannot determine whether the association observed in our study population is a result of the same mechanisms that lead to an increased prevalence of osteoporosis among patients with homocystinuria.
This study suggests that the total homocysteine concentration is strongly associated with the risk of hip fracture. If the relationship proves to be one of cause and effect, this finding may have important implications for the development of interventions to prevent hip fractures, because total homocysteine concentrations can be effectively and easily modified by dietary intake of folic acid and vitamins B6 and B12. Further population-based research is needed to examine the role of homocysteine in osteoporosis and osteoporotic fracture and to determine whether nationwide folic acid fortification of food will help to reduce rates of hip fracture in the United States.
Supported by a grant from the National Institutes of Health (RO1 AR/AG 41398), a contract with the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195), a grant from the National Heart, Lung, and Blood Institute (HL54776), and an agreement (58-1950-9-001) and a contract (53-3K06-01) with the Department of Agriculture Research Service.
Dr. Jacques reports having received consulting fees from AgeWave and lecture fees from Syngenta and the Vitamin Nutrition Information Service. Dr. Selhub reports having received consulting fees from Eprova, Pamlab, Cooper Clinic, and VitaMed and holding a U.S. patent (10/020,634) on methods of vitamin composition in the treatment of osteoarthritis.
We are indebted to Dr. David T. Felson, who helped initiate the Framingham Osteoporosis Study and who helped adjudicate hip fractures.
Source Information
From the Hebrew Rehabilitation Center for Aged Research and Training Institute (R.R.M., E.J.S., K.E.B., M.T.H., D.P.K.); the Jean Mayer Department of Agriculture Human Nutrition Research Center on Aging, Tufts University (P.F.J., J.S., K.L.T.); the Department of Biostatistics, Boston University School of Public Health (L.A.C.); and the Harvard Medical School Division on Aging (M.T.H., D.P.K.) — all in Boston.
Address reprint requests to Dr. McLean at the Framingham Study, 73 Mt. Wayte Ave., Framingham, MA 01702, or at rmclean@mail.hrca.harvard.edu.
- References
References
1
Grieco AJ . Homocystinuria: pathogenetic mechanisms. Am J Med Sci 1977;273:120-132
CrossRef | Web of Science | Medline2
Boushey CJ ,Beresford SA ,Omenn GS ,Motulsky AG . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057
CrossRef | Web of Science | Medline3
Clarke R . An updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol 2002;31:70-71
CrossRef | Web of Science | Medline4
Morreels CL Jr ,Fletcher BD ,Weilbaecher RG ,Dorst JP . The roentgenographic features of homocystinuria. Radiology 1968;90:1150-1158
Web of Science | Medline5
Mudd SH ,Skovby F ,Levy HL , et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31
Web of Science | Medline6
Cooper C . The crippling consequences of fractures and their impact on quality of life. Am J Med 1997;103:Suppl 2A:12S-19S
CrossRef | Medline7
Ray NF ,Chan JK ,Thamer M ,Melton LJ III . Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35
CrossRef | Web of Science | Medline8
Browner WS ,Pressman AR ,Nevitt MC ,Cummings SR . Mortality following fractures in older women: the Study of Osteoporotic Fractures. Arch Intern Med 1996;156:1521-1525
CrossRef | Web of Science | Medline9
Dawber TR ,Meadors GF ,Moore FE Jr . Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-281
CrossRef | Web of Science10
Araki A ,Sako Y . Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52
CrossRef | Web of Science | Medline11
Ueland PM ,Refsum H ,Stabler SP ,Malinow MR ,Andersson A ,Allen RH . Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-1779
Web of Science | Medline12
Selhub J ,Jacques PF ,Wilson PW ,Rush D ,Rosenberg IH . Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698
CrossRef | Web of Science | Medline13
Kiel DP ,Felson DT ,Anderson JJ ,Wilson PWF ,Moskowitz MA . Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med 1987;317:1169-1174
Full Text | Web of Science | Medline14
Kiel DP ,Felson DT ,Hannan MT ,Anderson JJ ,Wilson PW . Caffeine and the risk of hip fracture: the Framingham Study. Am J Epidemiol 1990;132:675-684
Web of Science | Medline15
Felson DT ,Kiel DP ,Anderson JJ ,Kannel WB . Alcohol consumption and hip fractures: the Framingham Study. Am J Epidemiol 1988;128:1102-1110
Web of Science | Medline16
Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Heart Study: an epidemiological investigation of cardiovascular disease. Section 35. Survival following cardiovascular events: 30 year follow-up. Bethesda, Md.: National Heart, Lung, and Blood Institute, May 1988. (NIH publication no. 88-2969.)
17
Nagi SZ . An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc 1976;54:439-467
CrossRef | Medline18
Jette AM ,Pinsky JL ,Branch LG ,Wolf PA ,Feinleib M . The Framingham Disability Study: physical disability among commu-nity-dwelling survivors of stroke. J Clin Epidemiol 1988;41:719-726
CrossRef | Web of Science | Medline19
Folstein MF ,Folstein SE ,McHugh PR . “Mini-Mental State“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
CrossRef | Web of Science | Medline20
Bachman DL ,Wolf PA ,Linn RT , et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43:515-519
Web of Science | Medline21
Seshadri S ,Beiser A ,Selhub J , et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483
Full Text | Web of Science | Medline22
McKusick VA. Heritable disorders of connective tissue. 3rd ed. St. Louis: C.V. Mosby, 1966:150.
23
Kang AH ,Trelstad RL . A collagen defect in homocystinuria. J Clin Invest 1973;52:2571-2578
CrossRef | Web of Science | Medline24
Lubec B ,Fang-Kircher S ,Lubec T ,Blom HJ ,Boers GH . Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-162
Web of Science | Medline25
Masse PG ,Boskey AL ,Ziv I , et al. Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model. BMC Musculoskelet Disord 2003;4:2-2
CrossRef | Web of Science | Medline26
Browner WS ,Malinow MR . Homocyst(e)inaemia and bone density in elderly women. Lancet 1991;338:1470-1470
CrossRef | Web of Science | Medline27
Goyette P ,Sumner JS ,Milos R , et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200[Erratum, Nat Genet 1994;7:551.]
CrossRef | Web of Science | Medline28
Jacques PF ,Bostom AG ,Williams RR , et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9
Web of Science | Medline29
Miyao M ,Morita H ,Hosoi T , et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000;66:190-194
CrossRef | Web of Science | Medline30
Abrahamsen B ,Madsen JS ,Tofteng CL , et al. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish Osteoporosis Prevention Study. J Bone Miner Res 2003;18:723-729
CrossRef | Web of Science | Medline31
Jorgensen HL ,Madsen JS ,Madsen B , et al. Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures: a case control study in Danish postmenopausal women. Calcif Tissue Int 2002;71:386-392
CrossRef | Web of Science | Medline32
McLean RR ,Karasik D ,Selhub J , et al. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004;19:410-418
CrossRef | Web of Science | Medline33
Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-8797
34
Jacques PF ,Selhub J ,Bostom AG ,Wilson PWF ,Rosenberg IH . The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454
Full Text | Web of Science | Medline35
Nurk E ,Tell GS ,Nygard O ,Refsum H ,Ueland PM ,Vollset SE . Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Homocysteine Study. J Nutr 2001;131:1214-1216
Web of Science | Medline36
Clarke R ,Lewington S ,Donald A , et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk 2001;8:363-369
CrossRef | Medline37
Johnson MA ,Hawthorne NA ,Brackett WR , et al. Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr 2003;77:211-220
Web of Science | Medline38
Eastell R ,Vieira NE ,Yergey AL , et al. Pernicious anaemia as a risk factor for osteoporosis. Clin Sci (Lond) 1992;82:681-685
Web of Science | Medline39
Goerss JB ,Kim CH ,Atkinson EJ ,Eastell R ,O'Fallon WM ,Melton LJ III . Risk of fractures in patients with pernicious anemia. J Bone Miner Res 1992;7:573-579
CrossRef | Web of Science | Medline40
Dhonukshe-Rutten RA ,Lips M ,de Jong N , et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr 2003;133:801-807
Web of Science | Medline
- Citing Articles (175)
Citing Articles
1
Pawel Szulc. (2012) The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clinical Biochemistry
CrossRef2
Su-Jung Park, Ki-Jo Kim, Wan-Uk Kim, Il-Hoan Oh, Chul-Soo Cho. (2012) Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells. Journal of Bone and Mineral Metabolism
CrossRef3
Rifka C. Schulman, Aaron J. Weiss, Jeffrey I. Mechanick. (2011) Nutrition, Bone, and Aging: An Integrative Physiology Approach. Current Osteoporosis Reports 9:4, 184-195
CrossRef4
W.K. Kim, K. Ke, O.J. Sul, H.J. Kim, S.H. Kim, M.H. Lee, H.J. Kim, S.Y. Kim, H.T. Chung, H.S. Choi. (2011) Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. Journal of Cellular Biochemistry 112:11, 3159-3166
CrossRef5
Neetu Tyagi, Madhavi Kandel, Charu Munjal, Natia Qipshidze, Jonathan C. Vacek, Sathnur B. Pushpakumar, Naria Metreveli, Suresh C. Tyagi. (2011) Homocysteine mediated decrease in bone blood flow and remodeling: Role of folic acid. Journal of Orthopaedic Research 29:10, 1511-1516
CrossRef6
Hala Ahmadieh, Asma Arabi. (2011) Vitamins and bone health: beyond calcium and vitamin D. Nutrition Reviews 69:10, 584-598
CrossRef7
Ivana Rumbak, Vesna Žižić, Lea Sokolić, Selma Cvijetić, Romana Kajfež, Irena Colić Barić. (2011) Bone mineral density is not associated with homocysteine level, folate and vitamin B12 status. Archives of Gynecology and Obstetrics
CrossRef8
E.P. Paschalis, D.N. Tatakis, S. Robins, P. Fratzl, I. Manjubala, R. Zoehrer, S. Gamsjaeger, B. Buchinger, A. Roschger, R. Phipps, A.L. Boskey, E. Dall'Ara, P. Varga, P. Zysset, K. Klaushofer, P. Roschger. (2011) Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral. Bone
CrossRef9
N M van Schoor, K M A Swart, S M F Pluijm, M Visser, S Simsek, Y Smulders, P Lips. (2011) Cross-sectional and longitudinal association between homocysteine, vitamin B12 and physical performance in older persons. European Journal of Clinical Nutrition
CrossRef10
Saowanee Ngamruengphong, Grigorios I Leontiadis, Saba Radhi, Andrew Dentino, Kenneth Nugent. (2011) Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies. The American Journal of Gastroenterology 106:7, 1209-1218
CrossRef11
Alexey S. Chubarov, Makhmut M. Shakirov, Igor V. Koptyug, Renad Z. Sagdeev, Dmitry G. Knorre, Tatyana S. Godovikova. (2011) Synthesis and characterization of fluorinated homocysteine derivatives as potential molecular probes for 19F magnetic resonance spectroscopy and imaging. Bioorganic & Medicinal Chemistry Letters 21:13, 4050-4053
CrossRef12
Elaine W. Yu, Scott R. Bauer, Paul A. Bain, Douglas C. Bauer. (2011) Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies. The American Journal of Medicine 124:6, 519-526
CrossRef13
M.L. te Winkel, S.M.P.F. de Muinck Keizer-Schrama, R. de Jonge, R.D. van Beek, I.M. van der Sluis, W.C.J. Hop, R. Pieters, M.M. van den Heuvel-Eibrink. (2011) Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: A prospective study. Bone 48:3, 571-577
CrossRef14
Montserrat Carmen García-Casanova, M. Isabel Estevez-Pereda, M. Ángeles Valverde-Quintairos, Merçe Barenys de Lacha. (2011) Estado nutricional en individuos mayores de 65 años con diagnóstico de fractura de fémur. Enfermería Clínica 21:2, 75-83
CrossRef15
Sherifa A Hamed. (2011) Influences of bone and mineral metabolism in epilepsy. Expert Opinion on Drug Safety 10:2, 265-280
CrossRef16
Ioana Cotlarciuc, Toby Andrew, Tracy Dew, Gail Clement, Raj Gill, Gabriela Surdulescu, Roy Sherwood, Kourosh R. Ahmadi. (2011) The Basis of Differential Responses to Folic Acid Supplementation. Journal of Nutrigenetics and Nutrigenomics 4:2, 99-109
CrossRef17
Masataka Shiraki, Tatsuhiko Kuroda, Yumiko Shiraki, Shiro Tanaka, Tsuyoshi Higuchi, Mitsuru Saito. (2011) Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. Journal of Bone and Mineral Metabolism 29:1, 62-70
CrossRef18
Carsten Kriebitzsch, Lieve Verlinden, Guy Eelen, Natasja M. van Schoor, Karin Swart, Paul Lips, Mark B. Meyer, J Wesley Pike, Steven Boonen, Carsten Carlberg, Victor Vitvitsky, Roger Bouillon, Ruma Banerjee, Annemieke Verstuyf. (2011) 1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine pre-osteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. Journal of Bone and Mineral Researchn/a-n/a
CrossRef19
Janneke P van Wijngaarden, Rosalie AM Dhonukshe-Rutten, Natasja M van Schoor, Nathalie van der Velde, Karin MA Swart, Anke W Enneman, Suzanne C van Dijk, Elske M Brouwer-Brolsma, M. Carola C Zillikens, Joyce BJ van Meurs, Johannes Brug, Andre G Uitterlinden, Paul Lips, Lisette CPGM de Groot. (2011) Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence.. BMC Geriatrics 11:1, 80
CrossRef20
Diane Horowitz, Galina Marder, Richard Furie. 2011. Musculoskeletal System. , 921-942.
CrossRef21
Young Sun Chung, Seung Ho Hong, Kyung Tae Min, Dong Eun Shin, Jae Ho Lee, Yu Shik Shim, Jung Yong Ahn, Nam Keun Kim. (2010) Association of vascular endothelial growth factor gene polymorphisms with osteoporotic vertebral compression fractures in postmenopausal women. Genes & Genomics 32:6, 499-505
CrossRef22
Karen E Hansen, Andrea N Jones, Mary J Lindstrom, Lisa A Davis, Toni E Ziegler, Kristina L Penniston, Amy L Alvig, Martin M Shafer. (2010) Do proton pump inhibitors decrease calcium absorption?. Journal of Bone and Mineral Research 25:12, 2786-2795
CrossRef23
Michael A. Via, Emily Jane Gallagher, Jeffrey I. Mechanick. (2010) Bone physiology and therapeutics in chronic critical illness. Annals of the New York Academy of Sciences 1211:1, 85-94
CrossRef24
Yu–Xiao Yang, David C. Metz. (2010) Safety of Proton Pump Inhibitor Exposure. Gastroenterology 139:4, 1115-1127
CrossRef25
Michael Bodmer, Christian Meier, Marius E. Kraenzlin, Christoph R. Meier. (2010) Proton Pump Inhibitors and Fracture Risk. Drug Safety 33:10, 843-852
CrossRef26
Paolo Bucciarelli, Giuseppe Martini, Ida Martinelli, Elena Ceccarelli, Luigi Gennari, Rossella Bader, Roberto Valenti, Beatrice Franci, Ranuccio Nuti, Pier Mannuccio Mannucci. (2010) The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. European Journal of Internal Medicine 21:4, 301-305
CrossRef27
J.H. Holstein, M. Herrmann, J. Schmalenbach, R. Obeid, I. Ölkü, M. Klein, P. Garcia, T. Histing, T. Pohlemann, M.D. Menger, W. Herrmann, L. Claes. (2010) Deficiencies of folate and vitamin B12 do not affect fracture healing in mice. Bone 47:1, 151-155
CrossRef28
Joerg H. Holstein, Markus Herrmann, Christina Splett, Wolfgang Herrmann, Patric Garcia, Tina Histing, Moritz Klein, Karsten Kurz, Thomas Siebel, Tim Pohlemann, Michael D. Menger. (2010) Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis. Clinical Chemistry and Laboratory Medicine 48:6, 821-827
CrossRef29
M. Saito, K. Marumo, S. Soshi, Y. Kida, C. Ushiku, A. Shinohara. (2010) Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporosis International 21:4, 655-666
CrossRef30
K. Fujii, H. Nakashima, Y. Hashidzume. (2010) Isolation of folate-producing microalgae, from oligotrophic ponds in Yamaguchi, Japan. Journal of Applied Microbiology 108:4, 1421-1429
CrossRef31
Zora Krivošíková, Marica Krajčovičová-Kudláčková, Viera Spustová, Kornélia Štefíková, Martina Valachovičová, Pavel Blažíček, Tatiana Nĕmcová. (2010) The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the impact of vegetarian diet. European Journal of Nutrition 49:3, 147-153
CrossRef32
Roman Thaler, Silvia Spitzer, Monika Rumpler, Nadja Fratzl-Zelman, Klaus Klaushofer, Eleftherios P. Paschalis, Franz Varga. (2010) Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone 46:3, 703-709
CrossRef33
Seung Hun Lee, Mi Jung Kim, Beom-Jun Kim, Sung Reul Kim, Sail Chun, Jin Sook Ryu, Ghi Su Kim, Myoung Chong Lee, Jung-Min Koh, Sun Ju Chung. (2010) Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease. Movement Disorders 25:3, 332-340
CrossRef34
M. Saito, K. Marumo. (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporosis International 21:2, 195-214
CrossRef35
Bart L.T. Vaes, Carolien Lute, Sebastian P. van der Woning, Ester Piek, Jenny Vermeer, Henk J. Blom, John C. Mathers, Michael Müller, Lisette C.P.G.M. de Groot, Wilma T. Steegenga. (2010) Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. Bone 46:2, 514-523
CrossRef36
Seung Hun Lee, Mi Jung Kim, Beom-Jun Kim, Sung Reul Kim, Sail Chun, Hong-Kyu Kim, Jin Sook Ryu, Ghi Su Kim, Myoung Chong Lee, Sun Ju Chung, Jung-Min Koh. (2010) Hyperhomocysteinemia Due to Levodopa Treatment as a Risk Factor for Osteoporosis in Patients with Parkinson’s Disease. Calcified Tissue International 86:2, 132-141
CrossRef37
Nigel D. Toussaint, Grahame J. Elder, Peter G. Kerr. (2010) A Rational Guide to Reducing Fracture Risk in Dialysis Patients. Seminars in Dialysis 23:1, 43-54
CrossRef38
Javad Tavakkoly Bazzaz, Mahnaz Shojapoor, Habibollah Nazem, Parvin Amiri, Hossein Fakhrzadeh, Ramin Heshmat, Maryam Parvizi, Shirin Hasani Ranjbar, Mahsa M. Amoli. (2010) Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity. Molecular Biology Reports 37:1, 105-109
CrossRef39
P GARNERO. 2010. Assessment of Bone Turnover in Men Using Biochemical Markers. , 25-40.
CrossRef40
S CREMERS. 2010. Markers of Bone Remodeling and the Aging Skeleton. , 179-184.
CrossRef41
Jennifer L. Kelsey, Elizabeth J. Samelson. (2009) Variation in risk factors for fractures at different sites. Current Osteoporosis Reports 7:4, 127-133
CrossRef42
Anne Molloy. 2009. Folate–Vitamin B12 Interrelationships. , 381-408.
CrossRef43
Wolfgang Herrmann, Rima Obeid, Heike Schorr, Ulrich Hübner, Jürgen Geisel, Marga Sand-Hill, Nayyar Ali, Markus Herrmann. (2009) Enhanced bone metabolism in vegetarians – the role of vitamin B12 deficiency. Clinical Chemistry and Laboratory Medicine 47:11, 1381-1387
CrossRef44
L L N Husemoen, A Linneberg, M Fenger, B H Thuesen, T Jørgensen. (2009) Changes in lifestyle, biological risk factors and total homocysteine in relation to MTHFR C677T genotype: a 5-year follow-up study. European Journal of Clinical Nutrition 63:10, 1233-1240
CrossRef45
Kim TB Knoops, Avron Spiro, Lisette CPGM de Groot, Daan Kromhout, Wija A van Staveren, Katherine L Tucker. (2009) Do dietary patterns in older men influence change in homocysteine through folate fortification? The Normative Aging Study. Public Health Nutrition 12:10, 1760
CrossRef46
Nuray Bozkurt, Mehmet Erdem, Ercan Yılmaz, Ahmet Erdem, Aydan Biri, Ayca Kubatova, Murat Bozkurt. (2009) The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Archives of Gynecology and Obstetrics 280:3, 381-387
CrossRef47
Wako Urano, Takefumi Furuya, Eisuke Inoue, Atsuo Taniguchi, Tomohiko Urano, Shigeru Kotake, Chieko Sekita, Satoshi Inoue, Masako Hara, Shigeki Momohara, Naoyuki Kamatani, Hisashi Yamanaka. (2009) Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients. Journal of Bone and Mineral Metabolism 27:5, 574-583
CrossRef48
Pantelis Panopalis, Jinoos Yazdany. (2009) Bone health in systemic lupus erythematosus. Current Rheumatology Reports 11:3, 177-184
CrossRef49
L. Claes, J. Schmalenbach, M. Herrmann, I. Ölkü, P. Garcia, T. Histing, R. Obeid, H. Schorr, W. Herrmann, T. Pohlemann, M. D. Menger, J. H. Holstein. (2009) Hyperhomocysteinemia Is Associated with Impaired Fracture Healing in Mice. Calcified Tissue International 85:1, 17-21
CrossRef50
K. Zhu, J. Beilby, I. M. Dick, A. Devine, M. Soós, R. L. Prince. (2009) The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporosis International 20:7, 1183-1191
CrossRef51
M. Fayfman, J. Niu, Y.Q. Zhang, D.T. Felson, B. Sack, P. Aliabadi, J. Selhub, D.J. Hunter. (2009) The relation of plasma homocysteine to radiographic knee osteoarthritis. Osteoarthritis and Cartilage 17:6, 766-771
CrossRef52
S. Blouin, H.W. Thaler, C. Korninger, R. Schmid, J.G. Hofstaetter, R. Zoehrer, R. Phipps, K. Klaushofer, P. Roschger, E.P. Paschalis. (2009) Bone matrix quality and plasma homocysteine levels. Bone 44:5, 959-964
CrossRef53
Régis Levasseur. (2009) Bone tissue and hyperhomocysteinemia. Joint Bone Spine 76:3, 234-240
CrossRef54
Bart L. T. Vaes, Carolien Lute, Henk J. Blom, Nathalie Bravenboer, Teun J. Vries, Vincent Everts, Rosalie A. Dhonukshe-Rutten, Michael Müller, Lisette C. P. G. M. Groot, Wilma T. Steegenga. (2009) Vitamin B12 Deficiency Stimulates Osteoclastogenesis via Increased Homocysteine and Methylmalonic Acid. Calcified Tissue International 84:5, 413-422
CrossRef55
D. Nitsch, A. Mylne, P. J. Roderick, L. Smeeth, R. Hubbard, A. Fletcher. (2009) Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrology Dialysis Transplantation 24:5, 1539-1544
CrossRef56
Suruchi Khanna, Krishna K. Pillai, Divya Vohora. (2009) Insights into liaison between antiepileptic drugs and bone. Drug Discovery Today 14:7-8, 428-435
CrossRef57
Angela M Devlin, Tim J Green. (2009) Mechanisms of altered fatty acid and phospholipid levels in hyperhomocysteinemia. Clinical Lipidology 4:2, 159-166
CrossRef58
Xavier Roblin, Jean Marc Phelip. (2009) Biological Plausibility Between Proton Pump Inhibitory Therapy and Hip Fracture: Hypermocysteinemia Can Be the Link. The American Journal of Gastroenterology 104:4, 1052-1052
CrossRef59
Markus Herrmann, Andrea Tami, Britt Wildemann, Martin Wolny, Alexandra Wagner, Heike Schorr, Omid Taban-Shomal, Natalia Umanskaya, Steffen Ross, Patric Garcia, Ulrich Hübner, Wolfgang Herrmann. (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:3, 467-475
CrossRef60
Bradley A. Maron, Joseph Loscalzo. (2009) The Treatment of Hyperhomocysteinemia. Annual Review of Medicine 60:1, 39-54
CrossRef61
T. Cederholm. 2009. Nutrition and bone health in the elderly. , 252-270.
CrossRef62
Emiliana Damian Risberg, Farideh Jalilehvand, Bonnie O. Leung, Lars G. M. Pettersson, Magnus Sandström. (2009) Theoretical and experimental sulfur K-edge X-ray absorption spectroscopic study of cysteine, cystine, homocysteine, penicillamine, methionine and methionine sulfoxide. Dalton Transactions:18, 3542
CrossRef63
Christian Roux, Karine Briot, Laure Gossec, Sami Kolta, Tilo Blenk, Dieter Felsenberg, David M. Reid, Richard Eastell, Claus C. Glüer. (2009) Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole. Calcified Tissue International 84:1, 13-19
CrossRef64
Leane Hoey, Helene McNulty, Elizabeth M. E. McCann, Kelvin J. McCracken, John M. Scott, Barbara Blaznik Marc, Anne M. Molloy, Ciaren Graham, Kristina Pentieva. (2009) Laying hens can convert high doses of folic acid added to the feed into natural folates in eggs providing a novel source of food folate. British Journal of Nutrition 101:02, 206
CrossRef65
R A M Dhonukshe-Rutten, J H M de Vries, A de Bree, N van der Put, W A van Staveren, L C P G M de Groot. (2009) Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. European Journal of Clinical Nutrition 63:1, 18-30
CrossRef66
Ilhan Bayhan, Dilek Uygur, Nil Ugurlu, Gulnur Ozaksit. (2009) Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women. Rheumatology International 29:3, 263-266
CrossRef67
Timothy Kwok, Jones Chun-Man Chan. (2008) Vitamin B 12 and health in old age. Aging Health 4:6, 651-657
CrossRef68
Luciana Hannibal, Armend Axhemi, Alla V. Glushchenko, Edward S. Moreira, Nicola E. Brasch, Donald W. Jacobsen. (2008) Accurate assessment and identification of naturally occurring cellular cobalamins. Clinical Chemistry and Laboratory Medicine 46:12, 1739-1746
CrossRef69
J. A. Hyder, M. A. Allison, N. Wong, A. Papa, T. F. Lang, C. Sirlin, S. M. Gapstur, P. Ouyang, J. J. Carr, M. H. Criqui. (2008) Association of Coronary Artery and Aortic Calcium With Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study. American Journal of Epidemiology 169:2, 186-194
CrossRef70
Sonja Gamsjäger, Murat Kazanci, Eleftherios P. Paschalis, Peter Fratzl. 2008. Raman Application in Bone Imaging. , 225-267.
CrossRef71
Masataka Shiraki, Tomohiko Urano, Tatsuhiko Kuroda, Mitsuru Saito, Shiro Tanaka, Mariko Miyao-Koshizuka, Satoshi Inoue. (2008) The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. Journal of Bone and Mineral Metabolism 26:6, 595-602
CrossRef72
J.B. Richards, A.M. Valdes, J.P. Gardner, B.S. Kato, A. Siva, M. Kimura, X. Lu, M.J. Brown, A. Aviv, T.D. Spector. (2008) Homocysteine levels and leukocyte telomere length. Atherosclerosis 200:2, 271-277
CrossRef73
Necat Yilmaz, Esin Eren, Sadik Özmen. (2008) Effects of Physical Training on Bone Mineral Density in Postmenopausal Women. Medicina Sportiva 12:3, 61-66
CrossRef74
James M. Bolton, Colleen Metge, Lisa Lix, Heather Prior, Jitender Sareen, William D. Leslie. (2008) Fracture Risk From Psychotropic Medications. Journal of Clinical Psychopharmacology 28:4, 384-391
CrossRef75
Andrea Z. LaCroix, Jennifer S. Lee, LieLing Wu, Jane A. Cauley, Michael G. Shlipak, Susan M. Ott, John Robbins, J. David Curb, Meryl Leboff, Douglas C. Bauer, Rebecca D. Jackson, Charles L. Kooperberg, Steven R. Cummings. (2008) Cystatin-C, Renal Function, and Incidence of Hip Fracture in Postmenopausal Women. Journal of the American Geriatrics Society 56:8, 1434-1441
CrossRef76
Markus Herrmann, Natalia Umanskaya, Britt Wildemann, Graziana Colaianni, Thomas Widmann, Alberta Zallone, Wolfgang Herrmann. (2008) Stimulation of osteoblast activity by homocysteine. Journal of Cellular and Molecular Medicine 12:4, 1205-1210
CrossRef77
Philip F. Giampietro, Margaret Peterson, Cathy L. Raggio. (2008) Alterations in Bone Mineral Density in Marfan Syndrome and Homocystinuria. Clinical Reviews in Bone and Mineral Metabolism
CrossRef78
G. Abellan Kan, G. Gambassi, L. C. P. G. M. Groot, S. Andrieu, T. Cederholm, E. Andre, J. -R. Caudere, J. -R. Bonjour, P. Ritz, A. Salva, A. Sinclair, B. Vellas. (2008) Nutrition and aging. The Carla workshop. The Journal of Nutrition Health and Aging 12:6, 355-364
CrossRef79
L. N Borrell. (2008) Commentary: Health policies in the US: can they increase or decrease the gap between subgroups of the population? The case of folic acid. International Journal of Epidemiology 37:5, 1067-1068
CrossRef80
J. B. Dowd, A. E Aiello. (2008) Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US?. International Journal of Epidemiology 37:5, 1059-1066
CrossRef81
Anuradha Viswanathan, Francisco A. Sylvester. (2008) Chronic pediatric inflammatory diseases: Effects on bone. Reviews in Endocrine and Metabolic Disorders 9:2, 107-122
CrossRef82
Wolfgang Herrmann, Markus Herrmann. (2008) Is hyperhomocysteinemia a risk factor for osteoporosis?. Expert Review of Endocrinology & Metabolism 3:3, 309-313
CrossRef83
C. Turecek, N. Fratzl-Zelman, M. Rumpler, B. Buchinger, S. Spitzer, R. Zoehrer, E. Durchschlag, K. Klaushofer, E. P. Paschalis, F. Varga. (2008) Collagen Cross-Linking Influences Osteoblastic Differentiation. Calcified Tissue International 82:5, 392-400
CrossRef84
Pooneh Salari, Bagher Larijani, Mohammad Abdollahi. (2008) Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 5:2, 215-222
CrossRef85
Robin A. Alley, Emery L. Chen, Todd D. Beyer, Richard A. Prinz. (2008) Does homocysteine contribute to bone disease in hyperparathyroidism?. The American Journal of Surgery 195:3, 374-378
CrossRef86
P. Garnero. (2008) New Biochemical Markers of Bone Turnover. IBMS BoneKEy 5:3, 84-102
CrossRef87
Angelo Cagnacci, Bruno Bagni, Annalisa Zini, Marianna Cannoletta, Matteo Generali, Annibale Volpe. (2008) Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42:2, 314-320
CrossRef88
Katherine H Noe, Sara LP Schrader. (2008) Bone health and antiseizure drugs: diagnosis and management. Aging Health 4:1, 75-84
CrossRef89
Jonathan Golledge, Paul E. Norman. (2008) Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study. Human Genetics 123:1, 35-40
CrossRef90
Pawel Szulc, Douglas P Kiel, Pierre D Delmas. (2008) Calcifications in the Abdominal Aorta Predict Fractures in Men: MINOS Study. Journal of Bone and Mineral Research 23:1, 95-102
CrossRef91
L. Rejnmark, P. Vestergaard, A. P. Hermann, C. Brot, P. Eiken, L. Mosekilde. (2008) Dietary Intake of Folate, but not Vitamin B2 or B12, Is Associated with Increased Bone Mineral Density 5 Years after the Menopause: Results from a 10-Year Follow-Up Study in Early Postmenopausal Women. Calcified Tissue International 82:1, 1-11
CrossRef92
Stéphanie Badiou, Hélène Breton, Hélène Peyriere, Virginie Charasson, Arielle Crespel, Philippe Gelisse, Jean-Paul Cristol, Dominique Hillaire-Buys. (2008) Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels. European Journal of Clinical Pharmacology 64:1, 83-87
CrossRef93
Nahid Yazdanpanah, André G Uitterlinden, M Carola Zillikens, Mila Jhamai, Fernando Rivadeneira, Albert Hofman, Robert de Jonge, Jan Lindemans, Huibert AP Pols, Joyce B van Meurs. (2008) Low Dietary Riboflavin but Not Folate Predicts Increased Fracture Risk in Postmenopausal Women Homozygous for the MTHFR 677 T Allele. Journal of Bone and Mineral Research 23:1, 86-94
CrossRef94
Wolfgang Herrmann. (2007) Homocysteine research: alive and kicking!. Clinical Chemistry and Laboratory Medicine 45:12, 1571-1574
CrossRef95
Markus Herrmann, Natalia Umanskaya, Lydia Traber, Heinrich Schmidt-Gayk, Wolfgang Menke, Gerd Lanzer, Markus Lenhart, Johannes Peter Schmidt, Wolfgang Herrmann. (2007) The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clinical Chemistry and Laboratory Medicine 45:12, 1785-1792
CrossRef96
Nahid Yazdanpanah, M. Carola Zillikens, Fernando Rivadeneira, Robert de Jong, Jan Lindemans, André G. Uitterlinden, Huibert A.P. Pols, Joyce B.J. van Meurs. (2007) Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: The Rotterdam Study. Bone 41:6, 987-994
CrossRef97
Anna Maria Gori, Francesco Sofi, Rossella Marcucci, Betti Giusti, Gian Franco Gensini, Rosanna Abbate. (2007) Association between homocysteine, vitamin B 6 concentrations and inflammation. Clinical Chemistry and Laboratory Medicine 45:12, 1728-1736
CrossRef98
Rima Obeid, Andrew McCaddon, Wolfgang Herrmann. (2007) The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clinical Chemistry and Laboratory Medicine 45:12, 1590-1606
CrossRef99
Markus Herrmann, Johannes Peter Schmidt, Natalia Umanskaya, Alexandra Wagner, Omid Taban-Shomal, Thomas Widmann, Graziana Colaianni, Britt Wildemann, Wolfgang Herrmann. (2007) The role of hyperhomocysteinemia as well as folate, vitamin B 6 and B 12 deficiencies in osteoporosis – a systematic review. Clinical Chemistry and Laboratory Medicine 45:12, 1621-1632
CrossRef100
(2007) Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis. Clinical Chemistry and Laboratory Medicine 45:12, 1575-1581
CrossRef101
M. Baines, M.-B. Kredan, A. Davison, G. Higgins, C. West, W. D. Fraser, L. R. Ranganath. (2007) The Association Between Cysteine, Bone Turnover, and Low Bone Mass. Calcified Tissue International 81:6, 450-454
CrossRef102
Alla V. Glushchenko, Donald W. Jacobsen. (2007) Molecular Targeting of Proteins by L-Homocysteine: Mechanistic Implications for Vascular Disease. Antioxidants & Redox Signaling 9:11, 1883-1898
CrossRef103
P. Szulc, J. M. Kaufman, P. D. Delmas. (2007) Biochemical assessment of bone turnover and bone fragility in men. Osteoporosis International 18:11, 1451-1461
CrossRef104
Markus Herrmann, Johannes Schmidt, Natascha Umanskaya, Graziana Colaianni, Fuad Al Marrawi, Thomas Widmann, Alberta Zallone, Britt Wildemann, Wolfgang Herrmann. (2007) Stimulation of osteoclast activity by low B-vitamin concentrations. Bone 41:4, 584-591
CrossRef105
Shilpa N. Bhupathiraju, D. Lee Alekel, Jeanne W. Stewart, Laura N. Hanson, Kristine M. Shedd, Manju B. Reddy, Kathy B. Hanson, Marta D. Van Loan, Ulrike Genschel, Kenneth J. Koehler. (2007) Relationship of Circulating Total Homocysteine and C-Reactive Protein to Trabecular Bone in Postmenopausal Women. Journal of Clinical Densitometry 10:4, 395-403
CrossRef106
U. Sennerby, B. Farahmand, A. Ahlbom, S. Ljunghall, K. Michaëlsson. (2007) Cardiovascular diseases and future risk of hip fracture in women. Osteoporosis International 18:10, 1355-1362
CrossRef107
M. A. Périer, E. Gineyts, F. Munoz, E. Sornay-Rendu, P. D. Delmas. (2007) Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporosis International 18:10, 1329-1336
CrossRef108
Feray Soyupek, Sureyya Cerci, Sedat Yildiz, Mustafa Yildiz, Burcin Gumus. (2007) Effect of Homocysteine on Bone Mineral Density of Rats. Biological Trace Element Research 118:3, 255-259
CrossRef109
M J Martínez-Ramírez, S Palma, M A Martínez-González, A D Delgado-Martínez, C de la Fuente, M Delgado-Rodríguez. (2007) Dietary fat intake and the risk of osteoporotic fractures in the elderly. European Journal of Clinical Nutrition 61:9, 1114-1120
CrossRef110
Robert R. McLean, Marian T. Hannan. (2007) B vitamins, homocysteine, and bone disease: Epidemiology and pathophysiology. Current Osteoporosis Reports 5:3, 112-119
CrossRef111
Maria Rosa Biagini, Alessandro Tozzi, Elena Bongini, Marco Capanni, Andrea Galli, Stefano Milani, Calogero Surrenti. (2007) Association of Plasma Homocysteine With Bone Mineral Density in Postmenopausal Women With Osteoporosis or Osteopenia Affected by Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology 41:6, 635
CrossRef112
Clara Gram Gjesdal, Stein Emil Vollset, Per Magne Ueland, Helga Refsum, Haakon E Meyer, Grethe S Tell. (2007) Plasma Homocysteine, Folate, and Vitamin B12 and the Risk of Hip Fracture: The Hordaland Homocysteine Study. Journal of Bone and Mineral Research 22:5, 747-756
CrossRef113
Dong Zhao, Mike McIntosh, Harry Fein, Xueji Zhang. (2007) Comparison of Methionine α,γ-Lyase and Homocysteine α,γ-Lyase for Electrochemical Determination of Homocysteine. Electroanalysis 19:10, 1075-1083
CrossRef114
Steinar Hustad, Øivind Midttun, Jørn Schneede, Stein Emil Vollset, Tom Grotmol, Per Magne Ueland. (2007) The Methylenetetrahydrofolate Reductase 677C→T Polymorphism as a Modulator of a B Vitamin Network with Major Effects on Homocysteine Metabolism. The American Journal of Human Genetics 80:5, 846-855
CrossRef115
X. ROBLIN, J. M. PHELIP, M. GENEVOIS, V. DUCROS, B. BONAZ. (2007) Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 25:7, 797-804
CrossRef116
Joseph Levine, Eitan Gur, Ron Loewenthal, Tali Vishne, Tzvi Dwolatzky, Ingrid M. van Beynum, Ben-Ami Sela, Iris Vered, Galit Yosef, Daniel Stein. (2007) Plasma homocysteine levels in female patients with eating disorders. International Journal of Eating Disorders 40:3, 277-284
CrossRef117
Beth Kitchin, Sarah L. Morgan. (2007) Not just calcium and vitamin D: Other nutritional considerations in osteoporosis. Current Rheumatology Reports 9:1, 85-92
CrossRef118
H.-K. Kuo, K.-C. Liao, S. G. Leveille, J. F. Bean, C.-J. Yen, J.-H. Chen, Y.-H. Yu, T.-Y. Tai. (2007) Relationship of Homocysteine Levels to Quadriceps Strength, Gait Speed, and Late-Life Disability in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62:4, 434-439
CrossRef119
José A. Riancho, Carmen Valero, José L. Hernández, Fernando Ortiz, Ana Zarrabeitia, María A. Alonso, Nicolás Peña, M. Asunción Pascual, Jesús González-Macías, María T. Zarrabeitia. (2007) Association of the F352V variant of the Klotho gene with bone mineral density. Biogerontology 8:2, 121-127
CrossRef120
Wija van Staveren, Lisette de Groot. 2007. Nutritional concerns in old age. , 5-15.
CrossRef121
M. Baines, M.-B. Kredan, J. Usher, A. Davison, G. Higgins, W. Taylor, C. West, W.D. Fraser, L.R. Ranganath. (2007) The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40:3, 730-736
CrossRef122
Xiumei Hong, Yi-Hsiang Hsu, Henry Terwedow, Genfu Tang, Xue Liu, Shanqun Jiang, Xin Xu, Xiping Xu. (2007) Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 40:3, 737-742
CrossRef123
John O. Elliott, Mercedes P. Jacobson, Zulfi Haneef. (2007) Homocysteine and bone loss in epilepsy. Seizure 16:1, 22-34
CrossRef124
Paul Gerdhem, Kaisa K Ivaska, Anders Isaksson, Kim Pettersson, H Kalervo Väänänen, Karl J Obrant, Kristina Åkesson. (2007) Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women. Journal of Bone and Mineral Research 22:1, 127-134
CrossRef125
Martha Savaria Morris. (2006) Reply re: “Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?”. Bone 39:6, 1386-1387
CrossRef126
Markus Herrmann, Thomas Widmann, Wolfgang Herrmann. (2006) Letter re: “Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?”. Bone 39:6, 1385-1386
CrossRef127
J. A. Riancho, C. Valero, M. T. Zarrabeitia. (2006) MTHFR Polymorphism and Bone Mineral Density: Meta-Analysis of Published Studies. Calcified Tissue International 79:5, 289-293
CrossRef128
Elias Zintzaras, Theocharis Koufakis, Panayiotis D. Ziakas, Paraskevi Rodopoulou, Stavroula Giannouli, Michael Voulgarelis. (2006) A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. European Journal of Epidemiology 21:7, 501-510
CrossRef129
M Jadoul, J M Albert, T Akiba, T Akizawa, L Arab, J L Bragg-Gresham, N Mason, K-G Prutz, E W Young, R L Pisoni. (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney International 70:7, 1358-1366
CrossRef130
Nancy E Lane. (2006) Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nature Clinical Practice Rheumatology 2:10, 562-569
CrossRef131
L. Jørgensen, O. Joakimsen, E. B. Mathiesen, L. Ahmed, G. K. R. Berntsen, V. Fønnebø, R. Joakimsen, I. Njølstad, H. Schirmer, B. K. Jacobsen. (2006) Carotid Plaque Echogenicity and Risk of Nonvertebral Fractures in Women: A Longitudinal Population-Based Study. Calcified Tissue International 79:4, 207-213
CrossRef132
Ian McPhee Chapman. (2006) Nutritional Disorders in the Elderly. Medical Clinics of North America 90:5, 887-907
CrossRef133
Mitsuru Saito, Katsuyuki Fujii, Keishi Marumo. (2006) Degree of Mineralization-related Collagen Crosslinking in the Femoral Neck Cancellous Bone in Cases of Hip Fracture and Controls. Calcified Tissue International 79:3, 160-168
CrossRef134
Duk Jae Kim, Jung-Min Koh, Oksun Lee, Na Jung Kim, Young-Sun Lee, Yang Soon Kim, Joong-Yeol Park, Ki-Up Lee, Ghi Su Kim. (2006) Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 39:3, 582-590
CrossRef135
Gilbert M. Wilcox, Anthony R. Mattia. (2006) Celiac Sprue, Hyperhomocysteinemia, and MTHFR Gene Variants. Journal of Clinical Gastroenterology 40:7, 596-601
CrossRef136
Jung-Min Koh, Young-Sun Lee, Yang Soon Kim, Duk Jae Kim, Hong-Hee Kim, Joong-Yeol Park, Ki-Up Lee, Ghi Su Kim. (2006) Homocysteine Enhances Bone Resorption by Stimulation of Osteoclast Formation and Activity Through Increased Intracellular ROS Generation. Journal of Bone and Mineral Research 21:7, 1003-1011
CrossRef137
L. F. Fried, M. G. Shlipak, C. Stehman-Breen, A. Mittalhenkle, S. Seliger, M. Sarnak, J. Robbins, D. Siscovick, T. B. Harris, A. B. Newman, J. A. Cauley. (2006) Kidney Function Predicts the Rate of Bone Loss in Older Individuals: The Cardiovascular Health Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:7, 743-748
CrossRef138
M. Saito, K. Fujii, S. Soshi, T. Tanaka. (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporosis International 17:7, 986-995
CrossRef139
Juan Carlos Souto, José Manuel Soria. (2006) Plasma homocysteine and the genetics of cardiovascular disease. Future Cardiology 2:2, 169-178
CrossRef140
Devora Lieberman, Michael Friger, David Lieberman. (2006) Inpatient Rehabilitation Outcome After Hip Fracture Surgery in Elderly Patients: A Prospective Cohort Study of 946 Patients. Archives of Physical Medicine and Rehabilitation 87:2, 167-171
CrossRef141
Jaime F. Bravo, Carlos Wolff. (2006) Clinical study of hereditary disorders of connective tissues in a Chilean population. Arthritis & Rheumatism 54:2, 515-523
CrossRef142
C Papoutsakis, N Yiannakouris, Y Manios, E Papaconstantinou, F Magkos, K H Schulpis, A Zampelas, A L Matalas. (2006) The effect of MTHFR(C677T) genotype on plasma homocysteine concentrations in healthy children is influenced by gender. European Journal of Clinical Nutrition 60:2, 155-162
CrossRef143
P M Finglas, K de Meer, A Molloy, P Verhoef, K Pietrzik, H J Powers, D van der Straeten, M Jägerstad, G Varela-Moreiras, T van Vliet, R Havenaar, J Buttriss, A J A Wright. (2006) Research goals for folate and related B vitamin in Europe. European Journal of Clinical Nutrition 60:2, 287-294
CrossRef144
Elizabeth J. Samelson, Marian T. Hannan. (2006) Epidemiology of osteoporosis. Current Rheumatology Reports 8:1, 76-83
CrossRef145
J. Golbahar, M.A. Aminzadeh, S. A. Hamidi, G. R. Omrani. (2005) Association of red blood cell 5-methyltetrahydrfoate folate with bone mineral density in postmenopausal Iranian women. Osteoporosis International 16:12, 1894-1898
CrossRef146
G. Ravaglia, P. Forti, F. Maioli, L. Servadei, M. Martelli, N. Brunetti, L. Bastagli, D. Cucinotta, E. Mariani. (2005) Folate, But Not Homocysteine, Predicts the Risk of Fracture in Elderly Persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:11, 1458-1462
CrossRef147
Wayne Billon. 2005. Folate. , 93-110.
CrossRef148
Markus Herrmann, Marius Kraenzlin, Gerhard Pape, Marga Sand-Hill, Wolfgang Herrmann. (2005) Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clinical Chemistry and Laboratory Medicine 43:10, 1118-1123
CrossRef149
H.-K. KUO, C.-J. YEN, J. F. Bean. (2005) Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999-2002. Journal of Internal Medicine 258:4, 328-335
CrossRef150
Markus Herrmann, Thomas Widmann, Wolfgang Herrmann. (2005) Homocysteine – a newly recognised risk factor for osteoporosis. Clinical Chemistry and Laboratory Medicine 43:10, 1111-1117
CrossRef151
Donald W. Jacobsen, Otilia Catanescu, Patricia M. DiBello, John C. Barbato. (2005) Molecular targeting by homocysteine: a mechanism for vascular pathogenesis. Clinical Chemistry and Laboratory Medicine 43:10, 1076-1083
CrossRef152
Ralph Green, Joshua W. Miller. (2005) Vitamin B 12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clinical Chemistry and Laboratory Medicine 43:10, 1048-1051
CrossRef153
R. A. M. Dhonukshe-Rutten, M. Dusseldorp, J. Schneede, L. C. P. G. M. Groot, W. A. Staveren. (2005) Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. European Journal of Nutrition 44:6, 341-347
CrossRef154
H.-K. Kuo, F. A. Sorond, J.-H. Chen, A. Hashmi, W. P. Milberg, L. A. Lipsitz. (2005) The Role of Homocysteine in Multisystem Age-Related Problems: A Systematic Review. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:9, 1190-1201
CrossRef155
Angelika de Bree, Pilar Galan, Louise Mennen. 2005. The Role of Complementary Vitamins, Folate, Vitamin B6, and Vitamin B12, in Cardiovascular Disease. , 77-109.
CrossRef156
Martha Savaria Morris, Paul F. Jacques, Jacob Selhub. (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:2, 234-242
CrossRef157
Anne M Molloy, John M Scott. (2005) Nutrition and metabolism. Current Opinion in Lipidology 16:4, 494-496
CrossRef158
Juan Carlos Souto, Francisco Blanco-Vaca, José Manuel Soria, Alfonso Buil, Laura Almasy, Jordi Ordoñez-Llanos, Jesús Mª Martín-Campos, Mark Lathrop, William Stone, John Blangero, Jordi Fontcuberta. (2005) A Genomewide Exploration Suggests a New Candidate Gene at Chromosome 11q23 as the Major Determinant of Plasma Homocysteine Levels: Results from the GAIT Project. The American Journal of Human Genetics 76:6, 925-933
CrossRef159
Rosalie AM Dhonukshe-Rutten, Saskia MF Pluijm, Lisette CPGM de Groot, Paul Lips, Johannes H Smit, Wija A van Staveren. (2005) Homocysteine and Vitamin B12 Status Relate to Bone Turnover Markers, Broadband Ultrasound Attenuation, and Fractures in Healthy Elderly People. Journal of Bone and Mineral Research 20:6, 921-929
CrossRef160
Yoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, Tomohiro Kanoko, Kei Satoh. (2005) Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 36:4, 721-726
CrossRef161
Bo Abrahamsen, Jonna Skov Madsen, Charlotte Landbo Tofteng, Lis Stilgren, Else Marie Bladbjerg, Søren Risom Kristensen, Kim Brixen, Leif Mosekilde. (2005) Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 36:3, 577-583
CrossRef162
E. Seeman. (2005) Clinical and Basic Research Papers - February 2005 Selections. International Bone and Mineral Society Knowledge Environment 2:3, 1-5
CrossRef163
Anna Valerio, Goretta Baldo, Paolo Tessari. (2005) A rapid method to determine plasma homocysteine concentration and enrichment by gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 19:4, 561-567
CrossRef164
Kevin D. Cashman. (2005) Homocysteine and Osteoporotic Fracture Risk: A Potential Role for B Vitamins. Nutrition Reviews 63:1, 29-36
CrossRef165
Katherine L Tucker, Marian T Hannan, Ning Qiao, Paul F Jacques, Jacob Selhub, L Adrienne Cupples, Douglas P Kiel. (2005) Low Plasma Vitamin B12 Is Associated With Lower BMD: The Framingham Osteoporosis Study. Journal of Bone and Mineral Research 20:1, 152-158
CrossRef166
O. T
nz. (2005) Prophylaxe der Neuralrohrdefekte und anderer Fehlbildungen. Der Gyn
CrossRef167
Katherine L Tucker, Marian T Hannan, Ning Qiao, Paul F Jacques, Jacob Selhub, L Adrienne Cupples, Douglas P Kiel. (2005) Low Plasma Vitamin B12 Is Associated With Lower BMD: The Framingham Osteoporosis Study. Journal of Bone and Mineral Research 20:1, 152
CrossRef168
Mark A. Moyad. (2005) Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review for your patients. Urologic Oncology: Seminars and Original Investigations 23:1, 56-64
CrossRef169
P.G. Masse, J. Dosy, J.L. Jougleux, S.M. Donovan, M. Caissie, D.S. Howell. (2005) Bone Metabolic Imbalance Occurs at an Early Stage of Natural Menopause. Journal of Clinical Biochemistry and Nutrition 37:1, 19-27
CrossRef170
M. E. Suliman. (2004) Homocysteine in uraemia--a puzzling and conflicting story. Nephrology Dialysis Transplantation 20:1, 16-21
CrossRef171
H.M. Macdonald, F.E. McGuigan, W.D. Fraser, S.A. New, S.H. Ralston, D.M. Reid. (2004) Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 35:4, 957-964
CrossRef172
(2004) Homocysteine as a Predictive Factor for Hip Fracture in Older Persons. New England Journal of Medicine 351:10, 1027-1030
Full Text173
E. Seeman. (2004) Clinical and Basic Research Papers - May and June 2004 Selections. International Bone and Mineral Society Knowledge Environment 1:7, 1-3
CrossRef174
Raisz, Lawrence G., . (2004) Homocysteine and Osteoporotic Fractures — Culprit or Bystander?. New England Journal of Medicine 350:20, 2089-2090
Full Text175
Armando D’Angelo, Giuseppina Mazzola, Isabella Fermo. (2003) Gene-Gene and Gene-Environment Interactions in Mild Hyperhomocysteinemia. Pathophysiology of Haemostasis and Thrombosis 33:5-6, 337-341
CrossRef
- Letters
